Global Radiation Therapy Quality Assurance Phantoms Market Size is valued at USD 30.5 Mn in 2024 and is predicted to reach USD 57.8 Mn by the year 2034 at a 6.7% CAGR during the forecast period for 2025-2034.
Key Industry Insights & Findings from the Report:
One medical discipline that uses radiation to treat cancer is radiation oncology. As part of quality control methods, the machines are tested daily, monthly, and annually using phantoms. In the realm of medical imaging, phantoms are specially created objects that are utilized for the testing, grading, and calibration of various imaging equipment. Dose calibration, beam calibration, patient location, and treatment planning system are a few of the main areas examined during quality assurance using phantoms. The rising prevalence of diseases like cancer is anticipated to fuel the growth of the radiation therapy quality assurance phantoms market. Innovative imaging phantoms are in high demand due to the rise in diagnostic imaging facilities and the requirement for in-house calibration methods.
The growing need for improved phantoms is anticipated to be significantly influenced by the increased prevalence of diseases such as chronic ailments, cancers of all kinds, and heart failure. These phantoms can aid in examining the possibilities of imaging systems' early detection capabilities. Therefore, it is anticipated that using radiation therapy quality assurance phantoms to increase the effectiveness of equipment like X-rays, CT scan, and MRI will significantly contribute to market growth.
The market for radiation therapy quality assurance phantoms, on the other hand, is predicted to increase slowly over the timeline because of the rise in concerns over costs. The market for radiation treatment quality assurance phantoms is confronted with several problems, including greater end-user knowledge of safety and reliability procedures and strict government restrictions, which could somewhat restrain its global demand in the next few years.
and evaluate radiation therapy quality, rising cancer prevalence, and, most significantly, increasing demand for phantoms.
The radiation therapy quality assurance phantoms market is segmented on the basis of technology and therapy. Based on technology, the market is characterized by linear accelerators, cobalt-60, high-dose radiation, and low-dose radiation. Based on therapy, the market is characterized by external radiation therapy (Photon Beam Radiation Therapy, Advanced three-Dimensional Conformal Radiation Therapy (3-D CRT), Volumetric Modulated Arc Therapy (VMAT), Image Guided Radiation Therapy (IGRT), Stereotactic Radiation Therapy, Intraoperative Radiotherapy (IORT), Proton Beam Therapy & Neutron Beam Therapy) and internal radiation therapy or brachytherapy.
The linear accelerator sector held the largest market share. The increased cancer incidence and product technological advancements are expected to drive the medical linear accelerator industry's expansion. Additionally, most cancers are found after they are well advanced. So, as the prevalence of cancer rises, will a need for therapy, which is expected to drive the growth of the medical linear accelerator market. High-energy x-rays are used in medical linear accelerators to kill cancerous cells and tumors while sparing nearby healthy tissues. The growing use of machine learning (ML) and artificial intelligence (AI) is transforming the market, primarily by increasing the effectiveness of cancer therapy with devices like linear accelerators.
Brachytherapy is the type of radiation therapy that is most frequently used to treat cancer. Radiation therapy for the treatment of cancer includes brachytherapy. Catheters are used to insert radioactive materials into the body. Breast, head and neck, cervix, prostate, and ocular malignancies can all be treated with it. Following the planning of the treatment processes, brachytherapy quality assurance phantoms are used to assess area and volume, depth of penetration, distance, axial and lateral resolution, and geometric consistency. Additionally, the growing popularity of less invasive procedures will likely present more chances for the brachytherapy industry to expand in the coming years.
During the forecast period, North America dominated the market, with the US and Canada accounting for most of the industry's revenue. This is primarily due to the country's sophisticated healthcare infrastructure, government support for growing the number of medical imaging devices to boost this industry's efficiency, growth in imaging device sales, and patient-centric philosophy. The substantial presence of significant medical technology companies, the rise in the use of radiotherapy equipment, and the growing emphasis on developing cutting-edge technologies and methodical radiation therapy for better patient care in the region are all variables that contribute to the rapid growth. In addition, Asia Pacific is anticipated to experience a CAGR in revenue that is noticeably higher. Government funding and increased R&D efforts are leading to the creation and adoption of more effective solutions, fueling the global market's revenue expansion. Other significant driving forces include expanding public awareness of the advantages of utilizing cutting-edge technologies to improve patient care.
Report Attribute |
Specifications |
Market Size Value In 2024 |
USD 30.5 Million |
Revenue Forecast In 2034 |
USD 57.8 Million |
Growth Rate CAGR |
CAGR of 6.7% from 2025 to 2034 |
Quantitative Units |
Representation of revenue in US$ Million and CAGR from 2025 to 2034 |
Historic Year |
2021 to 2024 |
Forecast Year |
2025-2034 |
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
Segments Covered |
Technology, Therapy |
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
Competitive Landscape |
Computerized Imaging Reference Systems, Inc., Fluke Biomedical, IBA Dosimetry, Modus Medical Devices Inc., PTW Freiburg GmbH, Standard Imaging Inc., Sun Nuclear Corporation and The Phantom Laboratory, In |
Customization Scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Radiation Therapy Quality Assurance (QA) Phantoms Market Snapshot
Chapter 4. Global Radiation Therapy Quality Assurance (QA) Phantoms Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Technology Estimates & Trend Analysis
5.1. by Technology & Market Share, 2024 & 2034
5.2. Market Size (Value (US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Technology:
5.2.1. Linear Accelerators
5.2.2. Cobalt-60
5.2.3. High-Dose Radiation
5.2.4. Low-Dose Radiation
Chapter 6. Market Segmentation 2: by Therapy Estimates & Trend Analysis
6.1. by Therapy & Market Share, 2024 & 2034
6.2. Market Size (Value (US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Therapy:
6.2.1. External Radiation Therapy
6.2.1.1. Photon Beam Radiation Therapy
6.2.1.2. Advanced three-Dimensional Conformal Radiation Therapy (3-D CRT)
6.2.1.3. Volumetric Modulated Arc Therapy (VMAT)
6.2.1.4. Image Guided Radiation Therapy (IGRT)
6.2.1.5. Stereotactic Radiation Therapy
6.2.1.6. Intraoperative Radiotherapy (IORT)
6.2.1.7. Proton Beam Therapy
6.2.1.8. Neutron Beam Therapy
6.2.2. Internal Radiation Therapy or Brachytherapy
Chapter 7. Radiation Therapy Quality Assurance (QA) Phantoms Market Segmentation 3: Regional Estimates & Trend Analysis
7.1. North America
7.1.1. North America Radiation Therapy Quality Assurance (QA) Phantoms Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2021-2034
7.1.2. North America Radiation Therapy Quality Assurance (QA) Phantoms Market Revenue (US$ Million) Estimates and Forecasts by Therapy, 2021-2034
7.1.3. North America Radiation Therapy Quality Assurance (QA) Phantoms Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
7.2. Europe
7.2.1. Europe Radiation Therapy Quality Assurance (QA) Phantoms Market revenue (US$ Million) by Technology, 2021-2034
7.2.2. Europe Radiation Therapy Quality Assurance (QA) Phantoms Market revenue (US$ Million) by Therapy, 2021-2034
7.2.3. Europe Radiation Therapy Quality Assurance (QA) Phantoms Market revenue (US$ Million) by country, 2021-2034
7.3. Asia Pacific
7.3.1. Asia Pacific Radiation Therapy Quality Assurance (QA) Phantoms Market revenue (US$ Million) by Technology, 2021-2034
7.3.2. Asia Pacific Radiation Therapy Quality Assurance (QA) Phantoms Market revenue (US$ Million) by Therapy, 2021-2034
7.3.3. Asia Pacific Radiation Therapy Quality Assurance (QA) Phantoms Market revenue (US$ Million) by country, 2021-2034
7.4. Latin America
7.4.1. Latin America Radiation Therapy Quality Assurance (QA) Phantoms Market revenue (US$ Million) by Technology, 2021-2034
7.4.2. Latin America Radiation Therapy Quality Assurance (QA) Phantoms Market revenue (US$ Million) by Therapy, 2021-2034
7.4.3. Latin America Radiation Therapy Quality Assurance (QA) Phantoms Market revenue (US$ Million) by country, 2021-2034
7.5. Middle East & Africa
7.5.1. Middle East & Africa Radiation Therapy Quality Assurance (QA) Phantoms Market revenue (US$ Million) by Technology, 2021-2034
7.5.2. Middle East & Africa Radiation Therapy Quality Assurance (QA) Phantoms Market revenue (US$ Million) by Therapy, 2021-2034
7.5.3. Middle East & Africa Radiation Therapy Quality Assurance (QA) Phantoms Market revenue (US$ Million) by country, 2021-2034
Chapter 8. Competitive Landscape
8.1. Major Mergers and Acquisitions/Strategic Alliances
8.2. Company Profiles
8.2.1. Computerized Imaging Reference Systems, Inc.
8.2.2. Fluke Biomedical
8.2.3. IBA Dosimetry
8.2.4. Modus Medical Devices Inc.
8.2.5. PTW Freiburg GmbH
8.2.6. Standard Imaging Inc.
8.2.7. Sun Nuclear Corporation
8.2.8. The Phantom Laboratory, Inc.
8.2.9. Other Prominent Players
By Technology
By Therapy
By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.